Aisling Capital Partners IV LLC
Insider CIK 1737019 · SNSS 10% owner · ZSAN 10% owner · ELEV 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELEV Elevation Oncology, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 31,238 | — | $0 | 31,238 | SEC↗ |
| ELEV Elevation Oncology, Inc. | A Award deriv | 2022-06-17 | 2022-06-22 | 15,619 | — | $0 | 15,619 | SEC↗ |
| ELEV Elevation Oncology, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 8,000,000 | — | $0 | 0 | SEC↗ |
| ELEV Elevation Oncology, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 1,936,834 | — | $0 | 0 | SEC↗ |
| ELEV Elevation Oncology, Inc. | P Buy | 2021-06-29 | 2021-07-01 | 187,500 | $16.00 | $3.00M | 2,834,910 | SEC↗ |
| ELEV Elevation Oncology, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 458,360 | — | $0 | 2,647,410 | SEC↗ |
| ELEV Elevation Oncology, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 1,893,232 | — | $0 | 2,189,050 | SEC↗ |
| ELEV Elevation Oncology, Inc. | A Award deriv | 2021-06-24 | 2021-06-28 | 31,238 | — | $0 | 31,238 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award | 2019-12-02 | 2019-12-06 | 689,655 | $1.45 | $1000.0K | 2,718,226 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2019-07-15 | 2019-07-15 | 2,500,000 | $0.60 | $1.50M | 10,100,000 | SEC↗ |
| ZSAN Zosano Pharma Corp | A Award | 2019-04-11 | 2019-04-12 | 428,571 | $3.50 | $1.50M | 2,028,571 | SEC↗ |